Literature DB >> 23973112

Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer.

Teiichi Sugiura1, Katsuhiko Uesaka, Kisho Mihara, Keiko Sasaki, Hideyuki Kanemoto, Takashi Mizuno, Yukiyasu Okamura.   

Abstract

BACKGROUND: Controversy persists as to whether positive operative margins are an independent prognostic factor for resected pancreatic cancer. This study evaluated the impact of the resection margin status on the patterns of recurrence and prognosis after resection for pancreatic cancer.
METHODS: A total of 208 patients with pancreatic cancer who underwent resection with curative intent were studied retrospectively. All patients underwent pancreatectomy (164 pancreatoduodenectomies, 42 distal pancreatectomies, and 2 total pancreatectomies) intended to achieve R0 resection. They were divided into three groups on the basis of the following margin status: R(>1 mm), R(0-1 mm), and R(0 mm). The postoperative survival and recurrence patterns were evaluated in relation to the margin status. Multivariate analyses were performed to evaluate the factors influencing the overall survival.
RESULTS: The resection margin was R(>1 mm) in 134 patients (65%), R(0-1 mm) in 40 (19%), and R(0 mm) in 34 patients (16%). The margin status correlated with the rate of local recurrence; 8% in R(>1 mm), 20% in R(0-1 mm), and 50% in R(0 mm) patients. In contrast, the incidence of recurrence at other sites, such as the lymph nodes, peritoneum, liver and other distant organs, were almost identical among the three groups. The median survival time was 26 months in R(>1 mm), 30 months in R(0-1 mm), and 23 months in R(0 mm) patients (P = not significant). The multivariate analyses revealed that lymph node metastases and poor differentiation were correlated with poor survival.
CONCLUSION: In the setting of pancreatectomy, when we evaluated the definitions of R0 resection, the margin status influenced the local recurrence rate but had no impact on the patients' survival.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23973112     DOI: 10.1016/j.surg.2013.04.015

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  28 in total

1.  A propensity score-matched analysis of robotic versus open pancreatoduodenectomy for pancreatic cancer based on margin status.

Authors:  Emanuele F Kauffmann; Niccolò Napoli; Francesca Menonna; Sara Iacopi; Carlo Lombardo; Juri Bernardini; Gabriella Amorese; Andrea Cacciato Insilla; Niccola Funel; Daniela Campani; Carla Cappelli; Davide Caramella; Ugo Boggi
Journal:  Surg Endosc       Date:  2018-06-25       Impact factor: 4.584

2.  Tumour origin and R1 rates in pancreatic resections: towards consilience in pathology reporting.

Authors:  Munita Bal; Swapnil Rane; Sanjay Talole; Mukta Ramadwar; Kedar Deodhar; Prachi Patil; Mahesh Goel; Shailesh Shrikhande
Journal:  Virchows Arch       Date:  2018-08-08       Impact factor: 4.064

Review 3.  A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma.

Authors:  James R Butler; Syed A Ahmad; Matthew H Katz; Jessica L Cioffi; Nicholas J Zyromski
Journal:  HPB (Oxford)       Date:  2016-02-01       Impact factor: 3.647

Review 4.  Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.

Authors:  Daniel Åkerberg; Daniel Ansari; Roland Andersson
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

5.  Surgical Indications of Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Body/Tail Cancer.

Authors:  Teiichi Sugiura; Yukiyasu Okamura; Takaaki Ito; Yusuke Yamamoto; Katsuhiko Uesaka
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

6.  Long-term survival after repeated resection of metachronous lung metastases from pStage IA pancreatic adenocarcinoma.

Authors:  Mamoru Miyasaka; Takehiro Noji; Kazuto Ohtaka; Ryohei Chiba; Shoki Sato; Yasuhito Shoji; Ryunosuke Hase; Tatsunosuke Ichimura; Satoshi Hirano; Naoto Senmaru
Journal:  Clin J Gastroenterol       Date:  2017-10-16

7.  The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

Authors:  Takeo Nitta; Toru Nakamura; Tomoko Mitsuhashi; Toshimichi Asano; Keisuke Okamura; Takahiro Tsuchikawa; Eiji Tamoto; Soichi Murakami; Takehiro Noji; Yo Kurashima; Yuma Ebihara; Yoshitsugu Nakanishi; Toshiaki Shichinohe; Satoshi Hirano
Journal:  Surg Today       Date:  2016-09-27       Impact factor: 2.549

8.  Revision of Surgical Margin under Frozen Section to Achieve R0 Status on Survival in Patients with Pancreatic Cancer.

Authors:  Zi Yin; Yu Zhou; Baohua Hou; Tingting Ma; Min Yu; Chuanzhao Zhang; Xin Lu; Zhixiang Jian
Journal:  J Gastrointest Surg       Date:  2018-05-18       Impact factor: 3.452

9.  Trends in Receipt and Timing of Multimodality Therapy in Early-Stage Pancreatic Cancer.

Authors:  Francesca Dimou; Helmneh Sineshaw; Abhishek D Parmar; Nina P Tamirisa; Ahmedin Jemal; Taylor S Riall
Journal:  J Gastrointest Surg       Date:  2015-10-26       Impact factor: 3.452

10.  Prognostic stratification based on a novel nomogram for left-sided pancreatic adenocarcinoma after surgical resection: a multi-center study.

Authors:  Zuyi Ma; Bowen Huang; Shanzhou Huang; Chunsheng Liu; Jiasheng Cao; Zehao Zheng; Zhenchong Li; Zixuan Zhou; Hongkai Zhuang; Yiping Zou; Linling Yang; Junchao Guo; Chuanzhao Zhang; Baohua Hou
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.